GARY SNIFFEN: Open Payments
NPI 1780293993 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$972 in 21 payments from 10 companies in 2025. Trend: 2023 $744 · 2024 $569 · 2025 $972
Food & beverage: $972
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 8 | $469 |
| AstraZeneca Pharmaceuticals LP | 2 | $243 |
| PFIZER INC. | 3 | $104 |
| Novartis Pharmaceuticals Corporation | 2 | $35 |
| CVRx, Inc. | 1 | $27 |
| SCPHARMACEUTICALS INC. | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| BridgeBio Pharma, Inc. | 1 | $19 |
| Impulse Dynamics (USA) Inc. | 1 | $18 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
Products named: CARDIOMEMS, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, AIRSUPRA, WAINUA, VYNDAQEL, LEQVIO, Barostim Neo System, FUROSCIX.
Industry payments across MI — which companies pay providers there.
